Inhibitors of the Tyrosine Kinase Ephb4. Part 1: Structure-Based Design and Optimization of a Series of 2,4-Bis-Anilinopyrimidines
Bardelle, C., Cross, D., Davenport, S., Kettle, J.G., Ko, E.J., Leach, A.G., Mortlock, A., Read, J., Roberts, N.J., Robins, P., Williams, E.J.(2008) Bioorg Med Chem Lett 18: 2776
- PubMed: 18434142 
- DOI: https://doi.org/10.1016/j.bmcl.2008.04.015
- Primary Citation of Related Structures:  
2VWU, 2VWV, 2VWW, 2VX0 - PubMed Abstract: 
A series of bis-anilinopyrimidines have been identified as potent inhibitors of the tyrosine kinase EphB4. Structural information from two alternative series identified from screening efforts was combined to identify the initial leads.
- AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK.
Organizational Affiliation: